Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 May 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 5MB, 226 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 

 

 

Export 11 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is Q  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Q
M. Quiroga, Shephard, E. A., Mounce, L. T. A., Carney, M., Hamilton, W. T., and Price, S. J., “Quantifying the impact of pre-existing conditions on the stage of oesophagogastric cancer at diagnosis: a primary care cohort study using electronic medical records”, Fam Pract, 2020.
J. K. Quint, Mullerova, H., DiSantostefano, R. L., Forbes, H., Eaton, S., Hurst, J. R., Davis, K., and Smeeth, L., “Validation of chronic obstructive pulmonary disease recording in the Clinical Practice Research Datalink (CPRD-GOLD)”, BMJ Open, vol. 4, p. e005540, 2014.
J. K. Quint, Moore, E., Lewis, A., Hashmi, M., Sultana, K., Wright, M., Smeeth, L., Chatzidiakou, L., Jones, R., Beevers, S., Kolozali, S., Kelly, F., and Barratt, B., “Recruitment of patients with Chronic Obstructive Pulmonary Disease (COPD) from the Clinical Practice Research Datalink (CPRD) for research”, NPJ Prim Care Respir Med, vol. 28, p. 21, 2018.
J. K. Quint, Herrett, E., Bhaskaran, K., Timmis, A., Hemingway, H., Wedzicha, J. A., and Smeeth, L., “Effect of beta blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare records”, Bmj, vol. 347, p. f6650, 2013.
J. K. Quint, Millett, E. R., Joshi, M., Navaratnam, V., Thomas, S. L., Hurst, J. R., Smeeth, L., and Brown, J. S., “Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study”, Eur Respir J, vol. 47, pp. 186-93, 2016.
J. K. Quint, O'Leary, C., Venerus, A., Myland, M., Holmgren, U., Varghese, P., Richter, H., Bizouard, G., and Cabrera, C., “Prescribing Pathways to Triple Therapy: A Multi-Country, Retrospective Observational Study of Adult Patients with Chronic Obstructive Pulmonary Disease”, Pulm Ther, vol. 6, pp. 333-350, 2020.
J. K. Quint, Venerus, A., O'Leary, C., Myland, M., Holmgren, U., Varghese, P., and Cabrera, C., “Prescribing Pathways to Triple Therapy: A Retrospective Observational Study of Adults with Chronic Obstructive Pulmonary Disease in the UK”, Int J Chron Obstruct Pulmon Dis, vol. 15, pp. 3261-3271, 2020.
J. K. Quint, O'Leary, C., Venerus, A., Holmgren, U., Varghese, P., and Cabrera, C., “Development and Validation of a Method to Estimate COPD Severity in Multiple Datasets: A Retrospective Study”, Pulm Ther, 2020.
N. Qizilbash, Gregson, J., Johnson, M. E., Pearce, N., Douglas, I., Wing, K., Evans, S. J. W., and Pocock, S. J., “BMI and risk of dementia in two million people over two decades: a retrospective cohort study”, Lancet Diabetes Endocrinol, vol. 3, pp. 431-436, 2015.
H. Qiu, Rhoads, G. G., Berlin, J. A., Marcella, S. W., and Demissie, K., “Initial metformin or sulphonylurea exposure and cancer occurrence among patients with type 2 diabetes mellitus”, Diabetes Obes Metab, vol. 15, pp. 349-57, 2013.
Y. Qian and Jick, S., “Proton pump inhibitor use and myocardial infarction: a nested study in the UK Clinical Practice Research Datalink”, Epidemiology, 2019.
[Page last reviewed 4 May 2021]